The Effect of Tomato Ketchup on Inflammation
The Protective Effect of Tomato Ketchup Consumption on Inflammation Induced Ex-vivo in Human Blood
1 other identifier
interventional
6
1 country
1
Brief Summary
The purpose of this study is to determine the inhibiting effects of a single consumption of tomato ketchup on inflammation which will be induced ex-vivo in human blood.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2011
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2011
CompletedFirst Posted
Study publicly available on registry
October 31, 2011
CompletedStudy Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2011
CompletedDecember 18, 2012
December 1, 2012
Same day
September 6, 2011
December 17, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Release of pro-and anti-inflammatory cytokines ex vivo
6h after consumption of tomato ketchup blood will be collected and challenged ex vivo with bacterial endotoxin (LPS) in order to elicit the release of pro- (TNF-alpha, IL-8) and anti-inflammatory cytokines (IL-10)
2 months
Secondary Outcomes (2)
Chemotaxis of monocytes ex vivo
2 months
Antioxidant plasma concentrations
2 months
Study Arms (2)
tomato ketchup meal
EXPERIMENTALPlacebo meal
PLACEBO COMPARATORInterventions
A single intake of 200 g tomato ketchup together with 200 g white cooked rice.
Self-prepared vinaigrette matching the qualitative and quantitative macronutrient composition of the tomato ketchup together with 200 g cooked rice resulting in a meal that is isocaloric to the tomato-ketchup meal
Eligibility Criteria
You may qualify if:
- BMI ≤ 30 kg/m2
- Age \>18 years
You may not qualify if:
- Occurence of any adverse event, in particular those which require the use of medication that might interfere with the effects and/or the uptake of the investigational products
- Intolerance of study products
- Occurence of a serious adverse event
- Use of supplements, functional foods and/or other products containing tomatoes, vitamins, antioxidants and polyphenolic compounds
- Use of a medically prescribed diet or slimming diet
- Vegetarian or vegan lifestyle
- Excessive alcohol consumption (\< 28 consumptions (approximately 250 g alcohol) per week)
- Participation in a clinical trial within 4 weeks before the study
- Non-compliance with the demands of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dept. of Toxicology, Maastricht University Medical Centre
Maastricht, Netherlands
Related Publications (3)
Palozza P, Parrone N, Simone RE, Catalano A. Lycopene in atherosclerosis prevention: an integrated scheme of the potential mechanisms of action from cell culture studies. Arch Biochem Biophys. 2010 Dec 1;504(1):26-33. doi: 10.1016/j.abb.2010.06.031. Epub 2010 Jul 3.
PMID: 20599665BACKGROUNDMateo Anson N, Aura AM, Selinheimo E, Mattila I, Poutanen K, van den Berg R, Havenaar R, Bast A, Haenen GR. Bioprocessing of wheat bran in whole wheat bread increases the bioavailability of phenolic acids in men and exerts antiinflammatory effects ex vivo. J Nutr. 2011 Jan;141(1):137-43. doi: 10.3945/jn.110.127720. Epub 2010 Nov 24.
PMID: 21106920BACKGROUNDSwennen EL, Bast A, Dagnelie PC. Immunoregulatory effects of adenosine 5'-triphosphate on cytokine release from stimulated whole blood. Eur J Immunol. 2005 Mar;35(3):852-8. doi: 10.1002/eji.200425423.
PMID: 15719372BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Aalt Bast, Prof, PhD
Maastricht University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 6, 2011
First Posted
October 31, 2011
Study Start
November 1, 2011
Primary Completion
November 1, 2011
Study Completion
December 1, 2011
Last Updated
December 18, 2012
Record last verified: 2012-12